The FDA Pharmacy Compounding Advisory Committee meeting held on 23 and 24th July voted to allow several controversial peptides for inclusion on …
Eli Lilly retatrutide drug trial has delivered more positive results from two additional Phase 3 studies in a late-stage clinical study. The …
The U.S. Food and Drug Administration (FDA) has officially approved a new lung cancer drug, Jideytro (zidesamtinib), by pharmaceutical giant GSK. This …
President Donald Trump has announced a phased tariff schedule on imported low-cost medicines, introducing a two-year grace period before imposing dramatic tax …
The U.S. Food and Drug Administration (FDA) has announced a nationwide drug recall alerton the Cetirizine Hydrochloride Tablets by Unique Pharmaceutical Laboratories …
The Central Drugs Standard Control Organisation (CDSCO), under the supervision of the Drug Controller General of India (DCGI), has officially granted marketing …
The Delaware Division of Public Health (DPH) confirmed the state’s first case of measles in Delaware since 2014. The patient was identified …
The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With the Personalis …
Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb and NVIDIA …
The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral PCSK9 inhibitor. …
The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The deal is …
Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority (SAHPRA). With …
The FDA Pharmacy Compounding Advisory Committee meeting held on 23 and 24th July voted to allow several controversial peptides for
Eli Lilly retatrutide drug trial has delivered more positive results from two additional Phase 3 studies in a late-stage clinical
The U.S. Food and Drug Administration (FDA) has officially approved a new lung cancer drug, Jideytro (zidesamtinib), by pharmaceutical giant
President Donald Trump has announced a phased tariff schedule on imported low-cost medicines, introducing a two-year grace period before imposing
The U.S. Food and Drug Administration (FDA) has announced a nationwide drug recall alerton the Cetirizine Hydrochloride Tablets by Unique
The Central Drugs Standard Control Organisation (CDSCO), under the supervision of the Drug Controller General of India (DCGI), has officially
The Delaware Division of Public Health (DPH) confirmed the state’s first case of measles in Delaware since 2014. The patient
The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With
Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb
The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral
The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The
Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority
